Lymphocytic Leukemia, Chronic Clinical Trials

A listing of Lymphocytic Leukemia, Chronic medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 332 clinical trials
Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic Leukemia

This study will evaluate real-life effectiveness and use in participants starting venetoclax treatment for Chronic Lymphocytic Leukemia (CLL).

chronic lymphocytic leukemia
lymphoid leukemia
venetoclax
  • 21 views
  • 23 Sep, 2021
  • 125 locations
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

Observational study aimed at describing the characteristics and outcome of CLL patients who started treatment with venetoclax-based regimens according to the local label outside clinical trials

venetoclax
chronic lymphocytic leukemia
lymphoid leukemia
chronic lymphocytic leukemia refractory
  • 0 views
  • 25 Jan, 2021
  • 4 locations
Long-term Follow-up Study of Patients Receiving CAR-20/19-T Cells

This protocol is designed as a long-term follow-up study of participants who will receive genetically modified autologous CAR-T cells as part of clinical trial at the Medical College of Wisconsin/ Froedtert Hospital-- Phase 1 Study of CAR-20/19-T Cells in Patients with Relapsed Refractory B Cell Malignancies (NCT03019055).

cancer
  • 40 views
  • 24 Jan, 2021
  • 1 location
Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia

Assessment of SARS-CoV2 (mRNA and adenovirus-based vaccines) and Conjugated Pneumococcal (PCV13) in Patients with Chronic Lymphocytic Leukemia

  • 0 views
  • 22 Aug, 2021
  • 1 location
Atrial Fibrillation in Patients Receiving Ibrutinib

Ibrutinib (a tyrosine kinase inhibitor targeting Bruton) is a standard of treatment in haematology. According to retrospective data, atrial fibrillation and systemic hypertension are common ibrutinib-related advserse events. The investigators aim at prospectively establishing the incidence of thesedrug related advsere events through clinical monitoring and attempt at identifying populations at …

ibrutinib
tyrosine
  • 0 views
  • 24 Jan, 2021
  • 1 location
B-cell Chronic Lymphoid Malignancies Markers

Lymphoid chronic B-cell malignancies are frequent pathologies that affect adults, with a very variable prognosis and treatment (some of them can remain untreated). The diagnosis of these malignancies relies on the study of the morphology of tumoral cells and the expression by these cells of several markers, mainly via a …

flow cytometry
lymphoma
marginal zone lymphoma
  • 0 views
  • 18 Jul, 2021
  • 1 location
Pharmacokinetics of Venetoclax in Patients With Acute Myeloid Leukemia

Venetoclax is a treatment for chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). However, the pharmacokinetic data in Chinese population, as well as the change of venetoclax

cancer
venetoclax
  • 0 views
  • 26 Jan, 2021
  • 1 location
SARS-CoV-2 Donor-Recipient Immunity Transfer

This study investigates whether donors with previous exposure to COVID-19 can pass their immunity by hematopoietic (blood) stem cell transplant (HCT) donation to patients that have not been exposed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the COVID19 infection. This study may provide critical information …

lymphoma
myeloid leukemia
granulocyte colony stimulating factor
leukemia
myelofibrosis
  • 0 views
  • 02 Sep, 2021
  • 1 location
Genomic and Proteomic Study of Richter Syndrome (CGPSR)

Biological study on Richter Syndrome (RS), an agressive lymphoma that arises from Chronic Lymphocytice Leukemia (CLL). RS presents with the same histological aspect as primitive Diffuse Large B

  • 0 views
  • 22 Jan, 2021
  • 1 location
Assessment of the Quality of Life of Patients With Lymphomas Treated With Oral Therapy

receive oral therapy at home. Ibrutinib, acalabrutinib, idelalisib, venetoclax and lenalidomide are oral therapies used in the treatment of Chronic Lymphoid Leukemia, Follicular Lymphoma, Waldenstrm's

  • 0 views
  • 11 Aug, 2021
  • 1 location